Category: Stents
Global Stents
-
Global Primary Sclerosing Cholangitis Market - 2024-2031
... is driven by factors such as the increasing prevalence of primary sclerosing cholangitis, research activities, technological advancements, research funding, and collaboration among key players. Inflammatory bowel disease, which is characterized by intestinal inflammation that results ... Read More
-
Vascular Grafts Market, Global, 2021–2029
... (TAA) stent grafts. Geographically, the study is segmented into 5 regions: North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). The study also focuses on key competitors. Established companies, ... Read More
-
Peripheral Vascular Devices And Equipment Global Market Report 2025
... vascular devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Bioabsorbable Stents Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Interventional Cardiology Devices And Equipment Global Market Report 2025
... cardiology devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Benign Prostatic Hyperplasia Devices
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. TURP, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$389.8 Million by the end ... Read More
-
Coronary Guidewires
... CAGR of 4.4% over the analysis period 2024-2030. Nitinol-Based Guidewires, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$550.2 Million by the end of the analysis ... Read More
-
Guidewires
... 4.2% over the analysis period 2024-2030. Stainless Steel Material, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$303.5 Million by the end of the analysis period. ... Read More
-
Drug Device Combination Products
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the ... Read More
-
Vascular Guidewires
... CAGR of 5.5% over the analysis period 2024-2030. Coronary Guidewires, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$786.2 Million by the end of the analysis ... Read More
-
Vascular Stents
... CAGR of 4.3% over the analysis period 2024-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.2 Billion by the end of the analysis ... Read More
-
Intracranial Stents
... CAGR of 12.9% over the analysis period 2024-2030. Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$594.0 Million by the end of the analysis ... Read More
-
Venous Stents
... CAGR of 8.4% over the analysis period 2024-2030. Iliac Vein Stent Technology, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Aortic Stent Grafts
... at a CAGR of 4.9% over the analysis period 2024-2030. Abdominal Grafts, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Bioresorbable Stents
... CAGR of 12.1% over the analysis period 2024-2030. Polymer-based, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$905.2 Million by the end of the analysis period. ... Read More
-
Coatings for Medical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the end ... Read More
-
Pressure Guidewires
... CAGR of 8.6% over the analysis period 2024-2030. Flat Tipped Pressure Guidewires, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Non-Vascular Stents
... CAGR of 5.1% over the analysis period 2024-2030. Urology Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Prosthetic Heart Valves
... at a CAGR of 7.6% over the analysis period 2024-2030. Transcatheter Heart Valves, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$7.2 Billion by the end ... Read More
-
Vascular Grafts
... CAGR of 7.2% over the analysis period 2024-2030. Endovascular Aneurysm Repair (EVAR), one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Biodegradable Stents
... CAGR of 35.0% over the analysis period 2024-2030. Coronary Artery Stents, one of the segments analyzed in the report, is expected to record a 34.9% CAGR and reach US$15.6 Billion by the end of the ... Read More
-
Arterial Stents
... CAGR of 8.3% over the analysis period 2024-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Drug-Eluting Stents
... CAGR of 5.8% over the analysis period 2024-2030. Polymer-Free, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.9 Billion by the end of the analysis period. ... Read More
Research Assistance
